What if we could use a cancer's own byproduct to make drugs that destroy tumor cells from the inside? That is what Katsunori ...

Medically reviewed by Matthew Wosnitzer, MD Key Takeaways The main tests for kidney disease are an estimated glomerular filtration rate (eGFR) blood test and a urine albumin-to-creatinine ratio (UACR) ...

CEB353Ge kit delivers critical molecular evidence for phase 3 clinical trial evaluating recombinant human serum albumin ...

A retrospective cohort of 184 adults with malignancy found that low albumin around abscess diagnosis was associated with ...

Columbia’s Jai Radhakrishnan, MD, MS, explains how FSGS differs by phenotype and why new IgA nephropathy drugs reach so few ...

Two containers of the same research-grade albumin, sold under one product number, were found to carry 47.0 and 260.4 ...

A retrospective cross-sectional study of 1,948 older adults found that higher red blood cell distribution width-to-albumin ...

Chronic kidney disease (CKD) risk stratification that flagged high-risk patients in the electronic medical record, paired ...

Immunovant's IMVT-1402 aims to deliver best-in-class FcRn inhibition, but mixed data tempers confidence in its superiority.

Berlin keynote details Eos SENOLYTIX's pre-clinical results with mitochondrial-targeted geropeptide on healthspan and lifespan.

The FDA has expanded the indication of once-weekly basal insulin icodec-abae to include children and adolescents aged 10 years and older with type 2 diabetes.

FDA approves Hibsago (bepirovirsen) with NrtI therapy for adult chronic hepatitis B without cirrhosis; phase 3 trials show up to 20% functional cure at 72 weeks.